euters) AstraZeneca to acquire Ardea Biosciences (RDEA) for $1 billion ($32/share = 53.5% Amylin Pharmaceuticals said to be exploring a sale (hires CS & GS as advisers) Wal-Mart probe of possibly bribery in Mexico may prompt exec departures and fines (Bloomberg) Philips Q1 strong with solid top line d